7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1.5B | -$148M | 0.0% | -18.5% | — | $273M | $25M |
| 2024 | $1.5B | -$136M | 0.0% | -21.4% | -$110M | $184M | $39M |
| 2023 | $1.3B | -$58M | 0.0% | -13.3% | -$78M | $108M | $36M |
| 2022 | $1.0B | -$270M | 0.0% | -148.7% | -$128M | $94M | $18M |
| 2021 | $579M | -$25M | 0.0% | -3.9% | -$5M | — | $100935 |
| 2020 | $491M | -$31M | 0.0% | -5.8% | -$28M | $55M | $179512 |
| 2019 | $145M | -$42M | 0.0% | -27.2% | -$30M | — | $33M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $386M | $1M | 0.0% | 2.1% | — | $312M | $25M |
| Sep '25 | $345M | -$32M | 0.0% | -12.8% | — | $253M | $38M |
| Jun '25 | $356M | -$20M | 0.0% | -9.6% | — | $182M | $39M |
| Mar '25 | $373M | -$20M | 0.0% | -10.2% | — | $172M | $40M |
| Dec '24 | $371M | -$59M | 0.0% | -37.4% | -$57M | $184M | $39M |
| Sep '24 | $362M | -$47M | 0.0% | -29.5% | -$23M | $133M | $63M |
| Jun '24 | $379M | -$12M | 0.0% | -8.3% | -$10M | $134M | $73M |
| Mar '24 | $388M | -$19M | 0.0% | -11.3% | -$20M | $120M | $27M |
| Dec '23 | $347M | -$25M | 0.0% | -18.5% | -$16M | $108M | $36M |
| Sep '23 | $288M | -$13M | 0.0% | -11.7% | -$8M | $108M | $53M |
| Jun '23 | $329M | -$10M | 0.0% | -6.4% | -$30M | $108M | $60M |
| Mar '23 | $302M | -$9M | 0.0% | -16.2% | -$24M | $108M | $7M |
| Dec '22 | $258M | -$94M | 0.0% | -207.8% | -$32M | $94M | $18M |
| Sep '22 | $248M | -$11M | 0.0% | -24.2% | -$22M | $80M | $34M |
| Jun '22 | $269M | -$154M | 0.0% | -338.5% | -$46M | $81M | $63M |
| Mar '22 | $274M | -$11M | 0.0% | -19.1% | -$29M | $82M | $110M |
| Dec '21 | $127M | -$60M | 0.0% | -49.0% | -$12M | — | $100935 |
| Sep '21 | $156M | -$32M | 0.0% | -18.0% | -$7M | — | $4M |
| Jun '21 | $145M | -$29M | 0.0% | -18.0% | -$22M | — | $16M |
| Mar '21 | $151M | -$25M | 0.0% | -8.6% | -$14M | — | $22M |
How the market has priced PIII against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, P3 Health Partners Inc.'s revenue has grown 24.3% per year. These are computed facts, not advice.
As of FY2025, P3 Health Partners Inc. reported $273M of total debt against $25M of cash.
In FY2025, gross margin was —, operating margin -18.5%, and net margin -10.1%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.